Remune immunotherapeutic: IMNR started a Phase I trial in 32 children with HIV.

The Immune Response Corp. (IMNR), Carlsbad, Calif. Product: Remune immunotherapeutic Indication: HIV Status: IMNR started a Phase I trial in 32 children with HIV. The trial will be divided into two gr...